ConductScience.org, home

Paper6131674

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.

Sircar JC and 2 others. Biochem Pharmacol, 1983. Cited by 64 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis. Papers, record 6131674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6131674

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
1983
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
3.29
iCite
Revised in PubMed
2023-12-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sircar JCJ C
2Schwender CFC F
3Carethers MEM E

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aminosalicylic AcidsMajor topic
Colitis, UlcerativeMajor topic
Lipoxygenase InhibitorsMajor topic
Glycine maxMajor topic
SulfasalazineMajor topic
Humans
Kinetics
Mesalamine

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
18475455Mechanism of action of 5-arninosalicylic acid.Mediators Inflamm1992https://conductscience.org/library/papers/18475455PubMed
8097101Comparison of the effect of oral sulphasalazine, sulphapyridine and 5-amino-salicylic acid on the in vivo antibody response to oral and systemic antigen.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8097101PubMed
6428914Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6428914PubMed
6201255The mucosal mast cell and its role in gastrointestinal allergic diseases.Clin Rev Allergy1984https://conductscience.org/library/papers/6201255PubMed
6150882Prostaglandins and ulcerative colitis.Gut1984https://conductscience.org/library/papers/6150882PubMed
6149981Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.Gut1984https://conductscience.org/library/papers/6149981PubMed
3458355Oxygen free radicals interact with indomethacin to cause gastrointestinal injury.Agents Actions1986https://conductscience.org/library/papers/3458355PubMed
2897215Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?Br J Pharmacol1988https://conductscience.org/library/papers/2897215PubMed
2889494The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.Br J Pharmacol1987https://conductscience.org/library/papers/2889494PubMed
2882965Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.Dig Dis Sci1987https://conductscience.org/library/papers/2882965PubMed
2877850Pharmacological and biochemical actions of sulphasalazine.Drugs1986https://conductscience.org/library/papers/2877850PubMed
2869652Sulphasalazine and experimental stress ulcers.Agents Actions1985https://conductscience.org/library/papers/2869652PubMed
2866075Modulation of human colonic arachidonic acid metabolism by sulfasalazine.Dig Dis Sci1985https://conductscience.org/library/papers/2866075PubMed
2864817Indomethacin-induced intestinal ulcers in rats: effects of salicylazosulfapyridine and dexamethasone.Agents Actions1985https://conductscience.org/library/papers/2864817PubMed
2831016Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites.Dig Dis Sci1988https://conductscience.org/library/papers/2831016PubMed
27028895-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine.Dig Dis Sci1989https://conductscience.org/library/papers/2702889PubMed
2664059Inflammatory intermediaries in inflammatory bowel disease.Int J Colorectal Dis1989https://conductscience.org/library/papers/2664059PubMed
2568163Inflammatory bowel disease.CMAJ1989https://conductscience.org/library/papers/2568163PubMed
2567266Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.Gut1989https://conductscience.org/library/papers/2567266PubMed
13597455-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.Agents Actions1992https://conductscience.org/library/papers/1359745PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6131674

GET https://conductscience.org/api/papers/v1/6131674/authors